Mostrar el registro sencillo del ítem
dc.contributor.author | Pedro-Cuesta, Jesus de | |
dc.contributor.author | Almazan-Isla, Javier | |
dc.contributor.author | Tejedor Romero, Laura | |
dc.contributor.author | Ruiz-Tovar, Maria | |
dc.contributor.author | Avellanal, Fuencisla | |
dc.contributor.author | Rábano, Alberto | |
dc.contributor.author | Calero, Miguel | |
dc.contributor.author | Garcia Lopez, Fernando Jose | |
dc.contributor.author | Spanish CJD Surveillance Group | |
dc.date.accessioned | 2022-04-06T10:51:08Z | |
dc.date.available | 2022-04-06T10:51:08Z | |
dc.date.issued | 2021-12 | |
dc.identifier.citation | Prion. 2021;15(1):94-106. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/13930 | |
dc.description.abstract | In Spain, human transmissible spongiform encephalopathies (TSEs) have been undergoing continuous surveillance for over 25 years. In 1995, the system was launched as an EU Concerted Action, with EU surveillance network procedures being incorporated from 2002 onwards. The aim of this report was to describe performance and outcomes of this surveillance system across the period 1993-2018. Neurology and public health specialists from every region reported cases to a central hub at the Carlos III Health Institute, Madrid. In all, eight accidentally transmitted cases and five definite variant Creutzfeldt-Jakob disease (vCJD) patients were reported. All vCJD cases were diagnosed between 2005 and 2008. Two of these were family/dietary-related and spatially linked to a third. Yearly incidence of sporadic CJD per million was 1.25 across the period 1998-2018, and displayed a north-south gradient with the highest incidence in La Rioja, Navarre and the Basque Country. Genetic TSEs were observed to be clustered in the Basque Country, with a 4-fold incidence over the national rate. A total of 120 (5.6%) non-TSE sporadic, conformational, rapidly progressing neurodegenerative and vascular brain disorders were reported as suspect CJD. We conclude that TSEs in Spain displayed geographically uneven, stable medium incidences for the sporadic and genetic forms, a temporal and spatial family cluster for vCJD, and decreasing numbers for dura-mater-associated forms. The vCJD surveillance, framed within the EU network, might require continuing to cover all prion disorders. There is need for further strategic surveillance research focusing on case definition of rapid-course, conformational encephalopathies and surgical risk. | es_ES |
dc.description.sponsorship | This work was basically funded by the Spain’s Ministry of Health and the Carlos III Health Institute. Additional funding was obtained from the EU Research Commission, Concerted Actions (BIOMED2 Contract No. BMH4-CT97-2216, QLRG3-CT-2002-81223), EU Joint Program – Neurodegenerative Disease Research (JPND – DEMTEST, Spanish Health Research Fund, FIS PI11/03021 and PI12/00045), EUROCJD (funded by DG SANCO, 2003201), research grants by the Carlos III Health Institute (PI08/0139), NEUROPRION (an EU Network of Excellence funded by Framework 6 Programme, FOOD CT 2004 056579), the Spanish Centro de Investigaciones en Enfermedades Neurológicas (CIEN C03-06), and Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED) networks. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Taylor & Francis | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.subject | Transmissible spongiform encephalopathies | es_ES |
dc.subject | Creutzfeldt-jakob disease | es_ES |
dc.subject | Epidemiology | es_ES |
dc.subject | Prion proteins | es_ES |
dc.subject | Registries | es_ES |
dc.subject | Surveillance | es_ES |
dc.subject | Spain | es_ES |
dc.title | Human prion disease surveillance in Spain, 1993-2018: an overview | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución-NoComercial 4.0 Internacional | * |
dc.identifier.pubmedID | 34120571 | es_ES |
dc.format.volume | 15 | es_ES |
dc.format.number | 1 | es_ES |
dc.format.page | 94-106 | es_ES |
dc.identifier.doi | 10.1080/19336896.2021.1933873 | es_ES |
dc.contributor.funder | Ministerio de Sanidad (España) | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | Unión Europea. Comisión Europea | es_ES |
dc.contributor.funder | Fundación Centro De Investigación De Enfermedades Neurológicas | es_ES |
dc.contributor.funder | Centro de Investigación Biomédica en Red - CIBERNED (Enfermedades Neurodegenerativas) | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1933-690X | es_ES |
dc.identifier.journal | Prion | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Epidemiología | es_ES |
dc.repisalud.centro | ISCIII::Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC) | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/QLRG3-CT-2002-81223 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/BMH4-CT97-2216 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/CT 2004 056579 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/2003201 | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/CIEN C03-06 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI11/03021 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI12/00045 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI08/0139 | es_ES |